Skip to main content
SpringerLink
Log in

Gonadotropins for Women with Unexplained Infertility

  • Chapter
  • First Online:
Unexplained Infertility

  • 1732 Accesses

Abstract

The use of gonadotropins in the treatment of unexplained infertility for women, who are apparently ovulating regularly, appears logically to be a futile exercise. However, whether by correcting subtle deficiencies in the ovulation process, improving the endocrine environment, and/or endometrial receptivity, ovarian stimulation with gonadotropins produces better pregnancy rates than either clomiphene citrate alone or intrauterine insemination (IUI) alone. When gonadotropin stimulation was combined with IUI, it produced superior pregnancy rates than either clomiphene citrate and IUI or IUI alone. It has been suggested, however, that gonadotropin stimulation combined with IUI does not produce superior birth rates compared with expectant treatment. Due to a lack of evidence-based studies in this field, the use of gonadotropin stimulation in the treatment of unexplained infertility, although now widely employed, remains controversial and further well-designed studies are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Smith S, Pfiefer SM, Collins J. Diagnosis and management of female infertility. JAMA. 2003;290:1767–70.

    Article  CAS  PubMed  Google Scholar 

  2. Collins JA, Burrows EA, Willan AR. The prognosis for live birth among untreated infertile couple. Fertl Steril. 1995;64:22–8.

    CAS  Google Scholar 

  3. Nuojua-Huttunen S, Tomas C, Bloigu R, Tuomivaara L, Martikainen H. Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome. Hum Reprod. 1999;14(3):698–703 (0268–1161).

    Article  CAS  PubMed  Google Scholar 

  4. Guzick DS, Carson SA, Coutifaris C, Overstreet JW, Factor-Litvak P, Steinkampf MP, Hill JA, Mastroianni L, Buster JE, Nakajima ST, Vogel DL, Canfield RE. Efficacy of superovulation and intrauterine insemination in the treatment of infertility. National Cooperative Reproductive Medicine Network. N Engl J Med. 1999 Jan 21;340(3):177–83.

    Article  CAS  PubMed  Google Scholar 

  5. Veltman-Verhulst SM, Cohlen BJ, Hughes E, Heineman MJ. Intra-uterine insemination for unexplained subfertility. Cochrane Database Syst Rev. 2012;9: CD001838. doi:10.1002/14651858.CD001838.pub4.

    PubMed  Google Scholar 

  6. Karlström PO, Bergh T, Lundkvist O. A prospective randomized trial of artificial insemination versus intercourse in cycles stimulated with human menopausal gonadotropin or clomiphene citrate. Fertil Steril. 1993 Mar;59(3):554–9.

    PubMed  Google Scholar 

  7. Costello MF. Systematic review of the treatment of ovulatory infertility with clomiphene citrate and intrauterine insemination. Aust N Z J Obstet Gynaecol. 2004 Apr;44(2):93–102 (0004–8666).

    Article  PubMed  Google Scholar 

  8. Steures P, van der Steeg JW, Hompes PG, Habbema JD, Eijkemans MJ, Broekmans FJ, Verhoeve HR, Bossuyt PM, van der Veen F, Mol BW, Collaborative Effort on the Clinical Evaluation in Reproductive Medicine. Intrauterine insemination with controlled ovarian hyperstimulation versus expectant management for couples with unexplained subfertility and an intermediate prognosis: a randomised clinical trial. Lancet. 2006 Jul;368(9531):216–21.

    Article  PubMed  Google Scholar 

  9. Brandes M, Hamilton CJ, van der Steen JO, de Bruin JP, Bots RS, Nelen WL, Kremer JA. Unexplained infertility: overall ongoing pregnancy rate and mode of conception. Hum Reprod. 2011;26(2):360–68.

    Article  CAS  PubMed  Google Scholar 

  10. NICE Guideline. Fertility: assessment and treatment for people with fertility problems. NICE clinical guideline (CG 156). 2013;1.8.1: 3–4

    Google Scholar 

  11. Nadeem R. Unexplained infertility: an exploration of women’s perceptions of diagnosis, treatment and decision-making. J Obstet Gynaecol. 2010 Jan;30(1):83–84 (0144–3615).

    Google Scholar 

  12. Gemzell CA, Diczfalusy E, Tillinger KG. Clinical effects of human pituitary follicle stimulating hormone (FSH). J Clin Endocrinol Metab. 1958;18:138–48.

    Google Scholar 

  13. European and Israeli Study group on highly purified Menotropin versus Recombinant Follicle Stimulating Hormone. Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomised. Comparative trial. Fertil Steril. 2002;78(3):520–8.

    Article  Google Scholar 

  14. Anderson AN, Devroey P, Arce JC. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomised assessor- blind controlled trial. Hum Reprod. 2006;21(12):3217–27.

    Article  Google Scholar 

  15. Coomarasamy A, Afnan M, Cheema D, van der Veen F, Bossuyt PM, van Wely M. Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis. Hum Reprod. 2008;23(2):310–5.

    Article  CAS  PubMed  Google Scholar 

  16. Trew GH, Brown AP, Gillard S, Blackmore S, Clewlow C, O’'Donohoe P, Wasiak R. In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: results from a European retrospective observational chart review. Reprod Biol Endocrinol. 2010;8:(137). doi:10.1186/1477-7827-8-137 (1477–7827).

    Google Scholar 

  17. Demirol A, Gurgan T. Comparison of different gonadotrophin preparations in intrauterine insemination cycles for the treatment of unexplained infertility: a prospective randomized study. Hum Reprod. 2007 Jan;22(1):97–100 (Epub 2006 Sep 5).

    Article  CAS  PubMed  Google Scholar 

  18. Ravelli A, Poso F, Gennarelli G, Moffa F, Grassi G, Massobrio M. Recombinant versus highly-purified, urinary follicle stimulating hormone (r-FSH vs HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis. Reprod Biol Endocrinol. 2006 Jul;4:38.

    Article  Google Scholar 

  19. Van Wely M, Kwan I, Burt AL, et al. Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. Cochrane Database Syst Rev. 2011;2:CD005354.

    PubMed  Google Scholar 

  20. Brown JB. Pituitary control of ovarian function–concepts derived from gonadotrophin therapy. Aust N Z J Obstet Gynecol. 1978 Feb;18(1):46–54.

    Article  CAS  Google Scholar 

  21. Scheele F, Schoemaker J. The role of follicle-stimulating hormone in the selection of follicles in human ovaries: a survey of the literature and a proposed model. Gynaecol Endocrinol. 1996;10:55–66.

    Article  CAS  Google Scholar 

  22. Fauser BC, Van Heusden AM. Manipulation of human ovary function: physiological concepts and clinical consequences. Endocr Rev. 1997;18:71–106.

    CAS  PubMed  Google Scholar 

  23. Practice Committee of the American Society for Reproductive Medicine. Effectiveness and treatment for unexplained infertility. Fertil Steril. 2006;86:S111–4.

    Google Scholar 

  24. Pittman JH, Hammoud A, Keye WR, Gurtcheff SE, Czajkowski L, Gibson M. Psychological and physical symptoms in women undergoing superovulation with clomiphene citrate: a double-blind, placebo-controlled, crossover study. Fertil Steril. 2011 Sept;96(3):S153 (0015–0282).

    Article  Google Scholar 

  25. Dankert T, Kremer JA, Cohlen BJ, Hamilton CJ, Pasker-de Jong PC, Straatman H, van Dop PA. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH foe ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility. Hum Reprod. 2007 Mar;22(3):792–7 (Epub 2006 Nov 16).

    Article  CAS  PubMed  Google Scholar 

  26. Berker B, Kahraman K, Taskin S, Sukur YE, Sonmezer M, Atabekoglu CS. Recombinant FSH versus clomiphene citrate for ovarian stimulation in couples with unexplained infertility and male subfertility undergoing intrauterine insemination: a randomized trial. Arch Gynecol Obstet. 2011 Dec;284(6):1561–6 (0932–0067;1432–0711).

    Article  CAS  PubMed  Google Scholar 

  27. Bhattacharya S, Harrild K, Mollison J, Wordsworth S, Tay C, Harrold A, McQueen D, Lyall H, Johnston L, Burrage J, Grossett S, Walton H, Lynch J, Johnstone A, Kini S, Raja A, Templeton A. Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial. BMJ (Clinical research ed.). 2008;337:a716 (1468–5833).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Hughes E, Brown J, Collins JJ, Vanderkerchove P. Clomiphene citrate for unexplained subinfertility in women. Cochrane Database Syst Rev 2010;(1):CD000057. doi:10.1002/14651858.CD000057.pub2.

    Google Scholar 

  29. Wordsworth S, Buchanan J, Mollison J, Harrild K, Robertson L, Tay C, Harrold A, McQueen D, Lyall H, Johnston L, Burrage J, Grossett S, Walton H, Lynch J, Johnstone A, Kini S, Raja A, Templeton A, Bhattacharya S. Clomifene citrate and intrauterine insemination as first-line treatments for unexplained infertility: are they cost-effective? Hum Reprod. 2011 Feb;26(2):369–75 (0268–1161; 1460–2350).

    Article  CAS  PubMed  Google Scholar 

  30. Massai MR, de Ziegler D, Lesobre V, Bergeron C, Frydman R, Bouchard P. Clomiphene citrate affects cervical mucus and endometrial morphology independently of the changes in plasma hormone levels induced by multiple follicular recruitment. Fertil Steril. 1993;59(6):1179–86.

    CAS  PubMed  Google Scholar 

  31. Holzer H, Casper R, Tulandi T. A new era in ovulation induction. Fertil Steril. 2006;85(2):277–84.

    Article  CAS  PubMed  Google Scholar 

  32. Pritts AE. Letrozole for ovulation induction and controlled ovarian stimulation. Curr Opin Obstet Gynaecol. 2010;22:289–94.

    Google Scholar 

  33. Baysoy A, Serdaroglu H, Jamal H, Karatekali E, Ozornek H, Attar E. Letrozole versus human menopausal gonadotropin in women undergoing intrauterine insemination. Reprod Miomed Online. 2006;13(2):208–12.

    Article  CAS  Google Scholar 

  34. Gregoriou O, Vlahos NF, Konidaris S, Papadias K, Botsis D, Creatsas GK. Randomized controlled trial comparing superovulation with letrozole versus recombinant follicle-stimulating hormone combined with intrauterine insemination for couples with unexplained infertility who had failed clomiphene citrate stimulation and intrauterine insemination. Fertil Steril. 2008 Sep;90(3):678–83 (Epub 2007 Oct 25).

    Article  CAS  PubMed  Google Scholar 

  35. Mitwally MF, Casper RF. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertile Steril. 2002;77(4):776–80.

    Article  Google Scholar 

  36. Bedaiwy MA, Forman R, Mousa NA, Al Inany HG, Casper RF. Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation. Hum Reprod. 2006;21(11):2838–44.

    Article  PubMed  Google Scholar 

  37. Barroso G, Menocal G, Felix H, Rojas-Ruiz JC, Arslan M, Oehninger S. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian stimulation: a prospective, randomized, blinded clinical trial. Fertil Steril. 2006;86(5):1428–31.

    Article  CAS  PubMed  Google Scholar 

  38. Badawy A, Elnashar A, Totongy M. Clomiphene citrate or aromatase inhibitors combined with gonadotropins for superovulation in women undergoing intrauterine insemination: a prospective randomised trial. J Obstet Gynaecol. 2010;30(6):617–21.

    Article  CAS  PubMed  Google Scholar 

  39. Goverde AJ, McDonnell J, Vermeiden JP, Schats R, Rutten FF, Schoemaker J. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost effectiveness analysis. Lancet. 2000;355:13–8.

    Article  CAS  PubMed  Google Scholar 

  40. Amer S. Gonadotropin induction of ovulation. Obstetrics, Gynaecology and Reproductive medicine Med. 2007;17(7):205–10.

    Article  Google Scholar 

  41. Simoni M, Nieschlag E, Gromoll J. Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Hum Reprod Update. 2002;8(5):413–21.

    Article  CAS  PubMed  Google Scholar 

  42. Cantineau AEP, Cohlen BJ, Heineman MJ. Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertility. Cochrane Database Syst Rev. 2007;2:CD005356. (10.1002/14651858.CD005356.pub2).

    Google Scholar 

  43. Manzi D, Dumez S, Scott LB, Nulsen JC. Selective use of luprolide acetate in women undergoing superovulation with intrauterine insemination results in significant improvement in pregnancy outcome. Fert Steril. 1995;63:866–73.

    CAS  Google Scholar 

  44. Cohlen BJ, te Velde ER, van Kooij RJ, Looman CW, Habbema JD. Controlled ovarian hyperstimulation and intrauterine insemination for treating male subfertility: a controlled study. Hum Reprod. 1998;13:1553–8.

    Article  CAS  PubMed  Google Scholar 

  45. Al-Inany H, Azab H, El-Khayat W, NadaA, El-Khattan E, Abou-Serra AM. The effectiveness of clomiphene citrate in LH surge suppression in women undergoing IUI: a randomized controlled trial. Fertil Steril. 2010 Nov; 94(6):2167–71.

    Google Scholar 

  46. Garliardi CL, Emmi AM, Weiss G, Schmidt CL. Gonadotropin-releasing hormone agonist improves the efficiency of controlled ovarian hyperstimulation/intrauterine insemination. Fertil Steril. 1991;55(5):939–44.

    Google Scholar 

  47. Lambalk CB, Leader A, Olivennes F, Fluker MR, Andersen AN, Ingerslev J, Khalaf Y, Avril C, Belaisch-Allart J, Roulier R, et al. Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial. Hum Reprod. 2006;21:632–9.

    Article  CAS  PubMed  Google Scholar 

  48. Gomez-Palomares JL, Julia B, Acevedo-Martin B, Martinez-Burgos M, Hernandez ER, Ricciarelli E. Timing ovulation for intrauterine insemination with a GnRH antagonist. Hum Reprod. 2005;20:368–72.

    Article  CAS  PubMed  Google Scholar 

  49. Crosignani PG, Somigliana E, Intrauterine Insemination Study Group. Effect of GnRH antagonists in FSH mildly stimulated intrauterine insemination cycles: a multicentre randomized trial. Hum Reprod. 2007 Feb;22(2):500–5 (Epub 2006 Oct 24).

    Article  CAS  PubMed  Google Scholar 

  50. Zikopoulos K, Kaponis A, Adonakis G, Sotiriadis A, Kalantaridou A, Georgiou I. A prospective randomized study comparing gonadotropin-releasing hormone agonists or gonadotropin-releasing hormone antagonists in couples with unexplained infertility and/or mild oligozoospermia. Fertil Steril. 2005;83(5):1354–62.

    Article  CAS  PubMed  Google Scholar 

  51. Schenker J, Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertil Steril. 1978;30:255–68.

    CAS  PubMed  Google Scholar 

  52. Cantineau AE, Janssen MJ, Cohlen BJ. Synchronised approach for intrauterine insemination in subfertile couples. Cochrane Database Syst Rev. 2010;14(4):CD006942.

    Google Scholar 

  53. Fauser BC, Devroey P. Reproductive biology and IVF: ovarian stimulation and luteal phase consequences. Trends Endocrinol Metab. 2003;14:236–42.

    Article  CAS  PubMed  Google Scholar 

  54. Olson JL, Reprod RW, Schreiber JR, Vaitukaitis YL. Shortened luteal phase after ovulation induction with human menopausal gonadotropin and chorionic gonadotropin. Fertil Steril. 1983;39:284–91.

    CAS  PubMed  Google Scholar 

  55. Miralpeix E, González-Comadran M, Solà I, Manau D, Carreras R, Checa MA. Efficacy of luteal phase support with vaginal progesterone in intrauterine insemination: a systematic review and meta-analysis. J Assist Reprod Genet. 2014 Jan;31(1):89–100.

    Article  PubMed Central  PubMed  Google Scholar 

  56. Hill MJ, Whitcomb BW, Lewis TD, Wu M, Terry N, DeCherney AH, Levens ED, Propst AM. Progesterone luteal support after ovulation induction and intrauterine insemination: a systematic review and meta-analysis. Fertil Steril. 2013 Nov;100(5):1373–80.

    Article  CAS  PubMed  Google Scholar 

  57. Gómez R, Soares SR, Busso C, Garcia-Velasco JA, Simón C, Pellicer A. Physiology and pathology of ovarian hyperstimulation syndrome. Semin Reprod Med. 2010;28:448–57. doi:10.1055/s-0030–1265670.

    Article  PubMed  Google Scholar 

  58. Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update. 2002;8:559–77.

    Article  CAS  PubMed  Google Scholar 

  59. Waldenstrom U, Kahn J, Marsk L, Nilsson S. High pregnancy rate and successful prevention of severe ovarian hyperstimulation syndrome by prolonged coasting of very hyperstimulated patients: a multicentre study. Human Reprod. 1999;14:294–7.

    Article  CAS  Google Scholar 

  60. Egbase PE, Makhsee M, Alsharhan M, Grudzinskas JG. Timed unilateral ovarian follicular aspiration prior to administration of human chorionic gonadotrophin for the prevention of severe ovarian hyperstimulation syndrome in in-vitro fertilization: a prospective randomized study. Hum Reprod. 1997;12:2603–6.

    Article  CAS  PubMed  Google Scholar 

  61. Gonen Y, Balakier H, Powell W, Casper RF. Use of gonadotrophin releasing hormone agonist to trigger follicular maturation for in-vitro fertilization. J Clin Endocrinol Metab. 1990;71:918–22.

    Article  CAS  PubMed  Google Scholar 

  62. Awonuga AO, Pittrof RJ, Zaidi J, Dean N, Jacobs HS, Tan SL. Elective cryopreservation of all embryos in women at risk of developing ovarian hyperstimulation syndrome may not prevent the condition but reduces the live birth rate. J Assist Reprod Genet. 1996;13:401–6.

    Article  CAS  PubMed  Google Scholar 

  63. Ozturk O, Templeton A. In-vitro fertilisation and risk of multiple pregnancy. Lancet. 2002 Jan;359(9302):232.

    Article  PubMed  Google Scholar 

  64. Heitmann RJ, Burney RO, Klein N, Chow GE. Elective single embryo transfer vs. double embryo transfer: evaluation of pregnancy and multiple gestation rates. Fertil Steril. 2011 Mar;95(4):S27 (0015–0282).

    Article  Google Scholar 

  65. Min JK, Hughes E, Young D, Gysler M, Hemmings R, Cheung AP, Goodrow GJ, Senikas V, Wong BC, Sierra S, Carranza-Mamane B, Case A, Dwyer C, Graham J, Havelock J, Lee F, Liu K, Vause T. Elective single embryo transfer following in vitro fertilization. J Obstet Gynaecol Can. (Journal d’'obstetrique et gynecologie du Canada). 2010 Apr;32(4):363–77 (1701–2163).

    PubMed  Google Scholar 

  66. Wainer R, Albert M, Dorion A, Bailly M, Bergère M, Lombroso R, Gombault M, Selva J. Influence of the number of motile spermatozoa inseminated and of their morphology on the success of intrauterine insemination. Hum Reprod. 2004 Sep;19(9):2060–5 (Epub 2004 Jul 8).

    Article  PubMed  Google Scholar 

  67. Reindollar RH, Regan MM, Neumann PJ, Levine B-S, Thornton KL, Alper MM. A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial. Fertil steril. 2010;94(3):888–899 (0015–0282).

    Article  PubMed  Google Scholar 

  68. Pandian Z, Gibreel A, Bhattacharya S. In vitro fertilisation for unexplained infertility. Cochrane Database Syst Rev. 2012;4:CD003357 (1469–493X).

    PubMed  Google Scholar 

  69. Land JA, Courtar DA, Evers JLH. Patient drop out in an assisted reproductive technology programme: implications for pregnancy rates. Fertil Steril. 1997;68:278–81.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fertility Centre, Homerton University Hospitals NHS Trust, Homerton Row, E9 6SR, Homerton, London, UK

    Anupa Nandi & Roy Homburg

Authors
  1. Anupa Nandi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roy Homburg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roy Homburg .

Editor information

Editors and Affiliations

  1. Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medical College, New York, New York, USA

    Glenn L. Schattman

  2. Andrology and Human Reproduction Clinic Referral Center for Male Reproduction, ANDROFERT, Campinas, São Paulo, Brazil

    Sandro C. Esteves

  3. Andrology Center & Center for Reproductive Medicine, Lerner College of Medicine Case Western Reserve University, Cleveland, Ohio, USA

    Ashok Agarwal

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Nandi, A., Homburg, R. (2015). Gonadotropins for Women with Unexplained Infertility. In: Schattman, G., Esteves, S., Agarwal, A. (eds) Unexplained Infertility. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2140-9_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2140-9_27

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2139-3

  • Online ISBN: 978-1-4939-2140-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation